Biotechnology News

November 7, 2012

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine announces the hiring of Marcus Klarl as the Vice President of Sales for Europe.

November 7, 2012

SAN DIEGO & LEIDEN, Netherlands--(BUSINESS WIRE)--Santarus, Inc. and Pharming Group NV announced that the Phase 3 clinical study to evaluate RUCONEST for the treatment of acute attacks of angioedema in patients with HAE met the primary...

November 6, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today presented key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart Association (AHA) in Los Angeles.

November 6, 2012

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product,...

November 6, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ® (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active...

November 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for...

November 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member...

November 6, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company, today announced financial and business results for the quarter ended September 30, 2012. Third Quarter 2012 Financial Results Maxygen reported a net loss...

November 6, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the third quarter and nine months ended September 30,...

November 6, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today announced results for its fourth quarter and fiscal year ended September 30, 2012.

November 6, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX has introduced directional messenger RNA (mRNA) kit for automated next generation sequencing (NGS) library preparation on the Apollo 324™ System.

November 6, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health plans to post for note holders its third-quarter 2012 financial results on Monday, November 12, 2012. The company will conduct a conference call for IMS’s note holders to review these results at 1:00...

November 6, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will issue its third quarter 2012 financial release on Friday, November 9, 2012 at approximately 8:00 a.m. ET. The press release will be followed...

November 6, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia, Inc. announced positive results from a Phase 1/2 heart failure trial where allogeneic and autologous mesenchymal (adult) stem cells (MSCs) were delivered via transendocardial injection.

November 6, 2012

BEND, Ore.--(BUSINESS WIRE)--Announcing the expansion of BiomarkerBase™ to include biomarkers in clinical trials. The expansion also includes lists of every FDA-approved IVD test for each biomarker in the database.

November 6, 2012

NEW YORK--(BUSINESS WIRE)--6th Annual ‘OneMedForum’ Announces Special Programming

November 6, 2012

SAN DIEGO--(BUSINESS WIRE)--BioSurplus announced today that it will be hosting a major lab equipment surplus liquidation auction for Geron, ACADIA Pharmaceuticals and a confidential San Diego biotech company.

November 6, 2012

FAIRFAX, Va.--(BUSINESS WIRE)--Cancer patients can now receive fully integrated care with medical oncologists and radiation oncologists working together as a team at Virginia Cancer Specialists

November 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in light of repeated clinical trial failures of investigational treatments,...

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SCYNEXIS today announced that results of a Phase 2a study of lead candidate SCY-635 for the treatment of the hepatitis C virus (HCV) will be the subject of an oral presentation at AASLD in Boston.

November 6, 2012

PHILADELPHIA--(BUSINESS WIRE)--The Shire ADHD Scholarship is for individuals in the US diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are pursuing higher education.

November 6, 2012

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: The following summons to the Annual General Meeting will be available at Diamyd Medical's website www.diamyd.com from Thursday...

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that four abstracts containing new data on treatment with Feraheme® (ferumoxytol) Injection for intravenous (IV) use in patients with iron deficiency...

November 6, 2012

NORWALK, Conn.--(BUSINESS WIRE)--A three-and-a-half-year review report of the biotechnology industry reveals a consistent slump in the M&A market.

November 6, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, has been chosen by AlwaysOn for a second consecutive year...

November 6, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today that it has completed a successful Phase 2a clinical evaluation of its novel therapeutic agent, UISH001, for treating urinary incontinence (UI).

November 6, 2012

EXTON, Penn.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that while Biogen Idec’s Avonex and Teva’s Copaxone continue to capture almost one-...

November 6, 2012

RESEARCH TRIANGLE PARK, NC--(BUSINESS WIRE)--New Product Planning groups contribute market approval strategies early for valuable compounds, find Cutting Edge Information.

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s research finds tracking key metrics, such as including physician reach, enhances medical publication teams’ value.

November 6, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (TASE: KMDA), an Israeli biopharmaceutical company, specializing in development, manufacturing and marketing of specialty plasma bio-therapeutics by intravenous or inhaled route for life saving...

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its recent clinical and business progress and reported its financial results for the third quarter of 2012. “We have made strong progress across...

November 6, 2012

RIO DE JANEIRO--(BUSINESS WIRE)--CryopraxisTM/CellPraxis® aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013. The phase IIA/B clinical trial study was...

November 6, 2012

ST. LOUIS--(BUSINESS WIRE)--Partek Flow, a web-based application for next generation sequencing applications including RNA-Seq, small RNA-Seq, Exome, and Targeted sequencing has been added to Illumina’s BaseSpace Apps.

November 6, 2012

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical announces the successful dosing of patients in a clinical study using a proprietary ocular microinjection platform to deliver drugs to treat retinal disease

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the third quarter ended September 30, 2012 and provided clinical program updates regarding its lead oncology drug ...

November 6, 2012

BEND, Ore.--(BUSINESS WIRE)--Bend, Oregon-based CRO/CMO, Agere, Enhances Spray Drying cGMP Capabilities to Serve Clients with One-stop-shopping

November 6, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix introduces high-density genotyping solution for genome-wide analysis of microRNA target sites, especially relevant for cancer genomics research. Preliminary study results presented at ASHG.

November 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today reported third quarter 2012 financial results and...

November 6, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Expanded leadership will advance Austin-based start-up company, Ortho Kinematics, Inc.

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at...

November 6, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 13, 2012 at the Lazard Capital Markets 9th Annual Healthcare Conference in New York City. The GTx presentation...

November 6, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November...

November 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix 510(k) Pre-Marketing Notification, Sherpa Pak Cardiac Transport System

November 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a patent infringement lawsuit against Cellectis.

November 6, 2012

BERLIN--(BUSINESS WIRE)--Today Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), announced the winners of the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0. This crowd-...

November 6, 2012

DUBLIN--(BUSINESS WIRE)--ICON Launches New Functional Service Provision (FSP) Strategy
FSP and resourcing services consolidated into a single division, DOCS

November 6, 2012

MILAN, Italy--(BUSINESS WIRE)--Sorin Group announced today the U.S. commercial launch of the Mitroflow Valsalva Conduit, the only Valsalva conduit graft approved by the U.S. FDA for use in combination with an aortic tissue valve.

November 6, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--New real-world data reinforces the positive safety and efficacy profile of Pradaxa® (dabigatran etexilate) in clinical practice for the prevention of venous thromboembolism (VTE) in patients undergoing total...